Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-007167
Filing Date
2017-02-02
Accepted
2017-02-02 17:06:12
Documents
1
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 19059
  Complete submission text file 0001209191-17-007167.txt   20689
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 EAST BAYSHORE ROAD SUITE 100 PALO ALTO CA 94303
Business Address
Ketchum Steven B (Reporting) CIK: 0001289884 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 17569181